NeueHealth (NEUE) Expected to Announce Quarterly Earnings on Thursday

NeueHealth (NYSE:NEUEGet Free Report) is projected to announce its earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of ($2.29) per share and revenue of $261.80 million for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

NeueHealth Price Performance

NEUE opened at $6.77 on Thursday. The business has a 50 day simple moving average of $7.32 and a 200-day simple moving average of $5.99. The stock has a market capitalization of $56.09 million, a P/E ratio of -0.13 and a beta of 0.56. NeueHealth has a 12 month low of $3.79 and a 12 month high of $7.73.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reduced their price objective on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Monday, December 9th.

Check Out Our Latest Research Report on NeueHealth

Insider Buying and Selling

In other news, CFO Jay Matushak sold 4,970 shares of NeueHealth stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.33, for a total value of $36,430.10. Following the completion of the sale, the chief financial officer now owns 17,747 shares of the company’s stock, valued at $130,085.51. The trade was a 21.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO George Lawrence Mikan III sold 16,803 shares of NeueHealth stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $4.18, for a total value of $70,236.54. Following the completion of the sale, the chief executive officer now directly owns 83,029 shares of the company’s stock, valued at approximately $347,061.22. This represents a 16.83 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 90,848 shares of company stock valued at $608,244. 64.30% of the stock is owned by insiders.

NeueHealth Company Profile

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Featured Articles

Earnings History for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.